title: [The results of research on the antioxidant emoksipin in clinical eye diseases].
abstract: Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.
authors.forename: E A
authors.initials: EA
authors.lastname: Egorov
authors.forename: A A
authors.initials: AA
authors.lastname: Shvedova
authors.forename: I A
authors.initials: IA
authors.lastname: Obraztsova
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000975:Antioxidants / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005123:Eye; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D010847:Picolines / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D010847:Picolines; C009820:6-methyl-2-ethyl-3-hydroxypyridine
vernacular_title: Rezul'taty issledovaniia antioksidanta émoksipina v klinike glaznykh bolezneĭ.